Specific targeting of wnt/β-catenin signaling in human melanoma cells by a dietary triterpene lupeol

Carcinogenesis

Volumn 31, Issue 10, 2010, Pages 1844-1853

  Tarapore, Rohinton S ^a,b   Siddiqui, Imtiaz A ^b   Saleem, Mohammad ^b,c   Adhami, Vaqar M ^b   Spiegelman, Vladimir S ^a,b   Mukhtar, Hasan ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYCLIN D1; CYCLINE; KI 67 ANTIGEN; LUPEOL; OSTEOPONTIN; WNT PROTEIN; ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 7; PENTACYCLIC TRITERPENE;

APOPTOSIS; ARTICLE; CELL GROWTH; CELL NUCLEUS; CELL PROLIFERATION; CELL VIABILITY; COLONY FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MELANOMA CELL; NUDE MOUSE; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TUMOR GROWTH; ANIMAL; ANTAGONISTS AND INHIBITORS; DOSE RESPONSE; DRUG EFFECTS; DRUG SCREENING; MALE; MELANOMA; METABOLISM; MOUSE; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; ANTICARCINOGENIC AGENTS; APOPTOSIS; BETA CATENIN; CASPASE 3; CASPASE 7; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MALE; MELANOMA; MICE; PENTACYCLIC TRITERPENES; SIGNAL TRANSDUCTION; WNT PROTEINS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77957806547     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgq169     Document Type: Article

References (52)

1. Jemal,A. et al. (2009) Cancer statistics, 2009. CA Cancer J. Clin., 59, 225-249.
2. Miller,A.J. et al. (2006) Melanoma. N. Engl. J. Med., 355, 51-65.
3. Khan,N. et al. (2008) Cancer chemoprevention through dietary antioxidants: progress and promise. Antioxid. Redox Signal., 10, 475-510.
4. Beveridge,T.H. et al. (2002) Phytosterol content in American ginseng seed oil. J. Agric. Food Chem., 50, 744-750.
5. Fernandez,M.A. et al. (2001) New insights into the mechanism of action of the anti-inflammatory triterpene lupeol. J. Pharm. Pharmacol., 53, 1533-1539.
6. Imam,S. et al. (2007) Two triterpenes lupanone and lupeol isolated and identified from Tamarindus indica linn. Pak. J. Pharm. Sci., 20, 125-127.
7. Saleem,M. (2009) Lupeol, a novel anti-inflammatory and anti-cancer dietary triterpene. Cancer Lett., 285, 109-115.
8. You,Y.J. et al. (2003) Antiangiogenic activity of lupeol from Bombax ceiba. Phytother. Res., 17, 341-344.
9. Fernandez,A. et al. (2001) Anti-inflammatory effect of Pimenta racemosa var. ozua and isolation of the triterpene lupeol. Farmaco, 56, 335-338.
10. Lima,L.M. et al. (2007) Anti-inflammatory and analgesic activities of the ethanolic extracts from Zanthoxylum riedelianum (Rutaceae) leaves and stem bark. J. Pharm. Pharmacol., 59, 1151-1158.
11. Vasconcelos,J.F. et al. (2008) The triterpenoid lupeol attenuates allergic airway inflammation in a murine model. Int. Immunopharmacol., 8, 1216-1221.
12. Latha,R.M. et al. (2001) A novel derivative pentacyclic triterpene and omega 3 fatty acid. Prostaglandins Leukot. Essent. Fatty Acids, 64, 81-85.
13. Sultana,S. et al. (2003) Lupeol, a triterpene, prevents free radical mediated macromolecular damage and alleviates benzoyl peroxide induced biochemical alterations in murine skin. Indian J. Exp. Biol., 41, 827-831.
14. Lira Wde,M. et al. (2008) Modulatory effect of Byrsonima basiloba extracts on the mutagenicity of certain direct and indirect-acting mutagens in Salmonella typhimurium assays. J. Med. Food, 11, 111-119.
15. Cmoch,P. et al. (2008) Synthesis of lupane-type saponins bearing mannosyl and 3,6-branched trimannosyl residues and their evaluation as anticancer agents. Carbohydr. Res., 343, 995-1003.
16. Saleem,M. et al. (2004) Lupeol modulates NF-kappaB and PI3K/Akt pathways and inhibits skin cancer in CD-1 mice. Oncogene, 23, 5203-5214.
17. Chin,L. et al. (2006) Malignant melanoma: genetics and therapeutics in the genomic era. Genes Dev., 20, 2149-2182.
18. Giles,R.H. et al. (2003) Caught up in a Wnt storm: wnt signaling in cancer. Biochim. Biophys. Acta, 1653, 1-24.
19. Weeraratna,A.T. (2005) A Wnt-er wonderland-the complexity of Wnt signaling in melanoma. Cancer Metastasis Rev., 24, 237-250.
20. Moon,R.T. (2005) Wnt/beta-catenin pathway. Sci. STKE, 2005, cm1.
21. Elcheva,I. et al. (2008) Overexpression of mRNA-binding protein CRD-BP in malignant melanomas. Oncogene, 27, 5069-5074.
22. Rubinfeld,B. et al. (1997) Stabilization of beta-catenin by genetic defects in melanoma cell lines. Science, 275, 1790-1792.
23. Rimm,D.L. et al. (1999) Frequent nuclear/cytoplasmic localization of β-catenin without exon 3 mutations in malignant melanoma. Am. J. Pathol., 154, 325-329.
24. Saleem,M. et al. (2008) Lupeol inhibits growth of highly aggressive human metastatic melanoma cells in vitro and in vivo by inducing apoptosis. Clin. Cancer Res., 14, 2119-2127.
25. Biechele,T.L. et al. (2008) Assaying-catenin/TCF transcription with β-catenin/TCF transcription-based reporter constructs. Methods Mol. Biol., 468, 99-110.
26. Korinek,V. et al. (1997) Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/-colon carcinoma. Science, 275, 1784-1787.
27. He,T.C. et al. (1998) Identification of c-MYC as a target of the APC pathway. Science, 281, 1509-1512.
28. Morin,P.J. et al. (1997) Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science, 275, 1787-1790.
29. Siddiqui,I.A. et al. (2008) Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis. Oncogene, 27, 2055-2063.
30. Siddiqui,I.A. et al. (2006) Inhibition of CWR22Rnu1 tumor growth and PSA secretion in athymic nude mice by green and black teas. Carcinogenesis, 27, 833-839.
31. Adhami,V.M. et al. (2004) Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer. Cancer Res., 64, 8715-8722.
32. Hu,J. et al. (2009) Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma. Cancer Res., 69, 6951-6959.
33. Afaq,F. et al. (2002) Botanical antioxidants for chemoprevention of photocarcinogenesis. Front. Biosci., 7, d784-d792.
34. Becker,J.C. et al. (2006) Molecularly targeted therapy for melanoma: current reality and future options. Cancer, 107, 2317-2327.
35. Nichenametla,S.N. et al. (2006) A review of the effects and mechanisms of polyphenolics in cancer. Crit. Rev. Food Sci. Nutr., 46, 161-183.
36. Nigam,N. et al. (2007) Preventive effects of lupeol on DMBA induced DNA alkylation damage in mouse skin. Food Chem. Toxicol., 45, 2331-2335.
37. Philchenkov,A. (2004) Caspases: potential targets for regulating cell death. J. Cell. Mol. Med., 8, 432-444.
38. Zhang,Z. et al. (2009) Secreted frizzled related protein 2 protects cells from apoptosis by blocking the effect of canonical Wnt3a. J. Mol. Cell. Cardiol., 46, 370-377.
39. Noubissi,F.K. et al. (2006) CRD-BP mediates stabilization of betaTrCP1 and c-myc mRNA in response to beta-catenin signalling. Nature, 441, 898-901.
40. Dorsky,R.I. et al. (2000) Direct regulation of nacre, a zebrafish MITF homolog required for pigment cell formation, by the Wnt pathway. Genes Dev., 14, 158-162.
41. Saito,H. et al. (2002) Melanocyte-specific microphthalmia-associated transcription factor isoform activates its own gene promoter through physical interaction with lymphoid-enhancing factor 1. J. Biol. Chem., 277, 28787-28794.
42. Saito,H. et al. (2003) Microphthalmia-associated transcription factor in the Wnt signaling pathway. Pigment Cell Res., 16, 261-265.
43. Yasumoto,K. et al. (2002) Microphthalmia-associated transcription factor interacts with LEF-1, a mediator of Wnt signaling. EMBO J., 21, 2703-2714.
44. Vachtenheim,J. et al. (2004) Microphthalmia transcription factor: a specific marker for malignant melanoma. Prague Med. Rep., 105, 318-324.
45. Shtutman,M. et al. (1999) The cyclin D1 gene is a target of the betacatenin/LEF-1 pathway. Proc. Natl Acad. Sci. USA, 96, 5522-5527.
46. Sauter,E.R. et al. (2002) p53 alone or in combination with antisense cyclin D1 induces apoptosis and reduces tumor size in human melanoma. Cancer Gene Ther., 9, 807-812.
47. Florenes,V.A. et al. (2000) Levels of cyclin D1 and D3 in malignant melanoma: deregulated cyclin D3 expression is associated with poor clinical outcome in superficial melanoma. Clin. Cancer Res., 6, 3614-3620.
48. Sauter,E.R. et al. (2002) Cyclin D1 is a candidate oncogene in cutaneous melanoma. Cancer Res., 62, 3200-3206.
49. Marneros,A.G. (2009) Tumor angiogenesis in melanoma. Hematol. Oncol. Clin. North Am., 23, 431-446., vii-viii.
50. Fecher,L.A. et al. (2009) Drug targeting of oncogenic pathways in melanoma. Hematol. Oncol. Clin. North Am., 23, 599-618., x.
51. Lopez-Otin,C. et al. (2009) Protective roles of matrix metalloproteinases: from mouse models to human cancer. Cell Cycle, 8, 3657-3662.
52. Hofmann,U.B. et al. (2005) Role of matrix metalloproteinases in melanoma cell invasion. Biochimie, 87, 307-314.